The pDNA-RVFV-GPC vaccine candidate demonstrated both safety and efficacy, including in all pregnant animals (25 sheep), with no cases of abortion, stillbirth, or fetal deformities observed, regardless of gestation stage. This evidence concerns the gene GYPC and abortion.